Emzor Reaffirms Commitment To Eradicating Malaria Across Africa

Emzor Pharmaceutical Industries Restricted, a number one title in Nigeria’s pharmaceutical sector, has reaffirmed its unwavering dedication to supporting each nationwide and worldwide efforts aimed toward combating the excessive prevalence of malaria in Nigeria and throughout Sub-Saharan Africa.

World Malaria Day, is well known on April twenty fifth every year. The day is used to focus on the burden of this illness to the world. This yr, the theme is ‘Malaria Ends with Us: Reinvest, Reimagine, Reignite’, and carefully aligns with Emzor’s imaginative and prescient of constructing a tangible influence within the international battle in opposition to malaria.

The top of selling and technique, at Emzor Pharmaceutical Industries Restricted, Mr. Kunle Faloye, whereas chatting with newsmen in Lagos, mentioned, “For years, Emzor has been on the forefront of malaria prevention and remedy—producing high-quality antimalarial drugs which might be each accessible and reasonably priced for tens of millions throughout Africa.Our dedication is mirrored in our funding in analysis, growth, and wide-reaching distribution networks, which have performed an important position in decreasing the malaria burden.”

To mark World Malaria Day 2025, Emzor organised a sequence of impactful neighborhood outreach actions, together with a well being stroll, free medical screenings, and the distribution of antimalarial medicine to susceptible populations.

Malaria continues to be a number one explanation for dying amongst pregnant ladies and youngsters beneath 5 in Africa. Emzor’s long-standing initiatives in malaria management embrace the manufacturing of important antimalarial medicine aimed toward decreasing maternal and toddler mortality charges.

Emzor at present produces over 20 antimalarial SKUs which embrace Maldox Sulfadoxine/Pyrimethamine), Lokmal (Artemether/Lumefantrine), Piramal TS (Dihydroartemisinin/Piperaquine), Diasunate (Artesunate/Amodiaquine), and Chloroquine, in numerous dosage kinds together with tablets, suspensions and dispersible tablets. Additional underscoring this dedication is Emzor’s multimillion-dollar funding within the manufacture of Energetic Pharmaceutical Substances (API), in our trendy manufacturing Pharmaceutical Campus situated in Sagamu, Ogun State.

The plant will initially deal with the manufacturing of antimalarial APIs (specifically Arthemeter, Lumefantrine, Sulfadoxine and Pyrimethamine). The chosen APIs present the WHO-recommended remedy of malaria for adults and youngsters, in addition to the chemo-preventive mixture therapies for malaria in each pregnant ladies and youngsters beneath 5.

This strategic funding boosts Nigeria’s capability to regionally produce a broad vary of antimalarial medicine, thereby enhancing entry to high-quality therapies throughout sub-Saharan Africa. The challenge additional underscores Emzor’s long-standing dedication to strengthening the pharmaceutical sector within the area. The challenge’s optimistic influence will scale back Nigeria’s dependence on imports from Asia, help GDP development and scale back the demand of international change, and scale back the price of manufacturing and entry to those life-saving medicines by the individuals who want them most.

“As we mark this vital day, Emzor stays steadfast in our resolve to contribute to international efforts towards malaria eradication. We’ll proceed to innovate, collaborate, and spend money on sustainable healthcare options that improve lives throughout Nigeria and the continent,” Faloye added.

“With roughly 95 p.c of all malaria instances and 96 p.c of the deaths occurring on the continent, that is predominantly an African downside and therefore, the options must also largely come from the continent. At Emzor, we’re taking part in our half and pioneering the API challenge on the continent undoubtedly matches into this,” the chairman of the Board of Administrators of Emzor Pharmaceutical Industries Restricted, Mr. Emeka Okoli added.

Emzor additionally works in partnership with native governments, NGOs, and communities to implement grassroots outreach programmes centered on schooling, prevention, analysis, and remedy. The corporate continues to supply sponsored and free drugs to pregnant ladies and youngsters, the teams most susceptible to malaria.